166 related articles for article (PubMed ID: 6944303)
1. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
Soga K; Furusho H; Mori S; Oki T
J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
[No Abstract] [Full Text] [Related]
2. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
[TBL] [Abstract][Full Text] [Related]
3. [Aclacinomycin A: a new antitumor antibiotic].
Egorov LV; Ivanitskaia LP; Navashin SM
Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
[No Abstract] [Full Text] [Related]
4. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
[TBL] [Abstract][Full Text] [Related]
5. Chemical modification of anthracycline antibiotics. I. Demethoxycarbonylation, 10-epimerization and 4-o-methylation of aclacinomycin A.
Tanaka H; Yoshioka T; Shimauchi Y; Matsuzawa Y; Oki T; Inui T
J Antibiot (Tokyo); 1980 Nov; 33(11):1323-30. PubMed ID: 6941951
[TBL] [Abstract][Full Text] [Related]
6. Trisarubicinol, new antitumor anthracycline antibiotic.
Yoshimoto A; Matsuzawa Y; Matsushita Y; Oki T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Nov; 34(11):1492-4. PubMed ID: 7319909
[No Abstract] [Full Text] [Related]
7. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
[No Abstract] [Full Text] [Related]
8. Neothramycins A and B, new antitumor antibiotics.
Takeuchi T; Miyamoto T; Ishizuka M; Naganawa H; Kondo S
J Antibiot (Tokyo); 1976 Jan; 29(1):93-6. PubMed ID: 931797
[No Abstract] [Full Text] [Related]
9. New anthracycline antibiotic, 2-hydroxyaclacinomycin A.
Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Jul; 34(7):916-8. PubMed ID: 6945302
[No Abstract] [Full Text] [Related]
10. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
[TBL] [Abstract][Full Text] [Related]
11. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
[TBL] [Abstract][Full Text] [Related]
12. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
[TBL] [Abstract][Full Text] [Related]
13. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Inui T
J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
[No Abstract] [Full Text] [Related]
14. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
[TBL] [Abstract][Full Text] [Related]
16. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
17. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
18. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
19. Reduction and hydrolysis of 2-hydroxyaclacinomycin A.
Matsuzawa Y; Oki T
J Antibiot (Tokyo); 1981 Nov; 34(11):1495-7. PubMed ID: 7319910
[No Abstract] [Full Text] [Related]
20. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
